NEW YORK (GenomeWeb News) – MDS today said that its first-quarter revenues rose 23 percent as sales from Molecular Devices exceeded the firm’s expectations.

For the three-month period ended Jan. 31, MDS reported revenues of $296 million, up from $241 million in the first quarter of 2007.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.